Scientific Meeting 2026
Registration closed on April 23 at 5:00 PM
| Hour | Title |
|---|---|
| 07:00am | Continental Breakfast and Registration |
| 07:55am | Welcoming Remarks Valentín Del Río, MD, FACC President & Governor ACC PR Chapter Ricardo Santiago, MD, FACC President Scientific Program Committee |
| 08:00am | Session A: From Evidence to Practice: Scientific Advances and Guideline Updates Best of ACC Late Breaking Clinical Trials Hadley Wilson, MD, MACC Update on the ACC/AHA Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery Purvi Parwani, MD, FACC Update on the ACC/AHA Guidelines for the Management of Patients with Acute Coronary Syndromes Hadley Wilson, MD, MACC |
| 09:00am | Discussion |
| 09:10am | Coffee Break – Exhibitor Visit |
| 09:25am | Session B: Emerging Paradigms in Coronary Disease Moderator: Ricardo Santiago, MD, FACC Microvascular dysfunction evaluation and treatment: an interventional cardiologist’s perspective Brett Wanamaker, MD, FACC, FSCAI Lipoprotein(a): The Next Major Target in Coronary Disease Prevention Hector Martinez, MD, FACC Heart Team Challenges: revascularization decision-making in the modern era Brett Wanamaker, MD, FACC, FSCAI |
| 10:25am | Discussion |
| 10:35am | Coffee Break – Exhibitor Visit |
| 10:50am | Session C: Cardiology Potpourri Approach to Severe Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy Jose Madrazo, MD Multi-modality Advanced Imaging in Cardiac Amyloidosis Juan Lopez-Mattei, MD, FACC |
| 11:30am | Discussion |
| 11:40am | Lunch Symposium |
| 01:10pm | Kick-Off Symposium |
| 01:30pm | Session D: Electrophysiology Fundamentals & Advances Moderator: Juan Sotomonte, MD, FACC Live Case: 3D-Mapping + FARAPULSE Pulsed Field Ablation (PFA) Operator: Hilton Franqui, MD, FACC / Francisco Perez, MD, FACC Non-thermal ablation Juan Sotomonte, MD, FACC Left Atrial Appendage Occlusion: The “Dual-Operator” Perspective Ricardo Perez, MD, FACC Newer Technologies in ICD Therapy (EV-ICD) Helder Hernandez, MD, FACC Leadless Pacing: Update 2026 Alfredo Lamela, MD |
| 03:00pm | Discussion |
| 03:10pm | Coffee Break – Exhibitor Visit |
| 03:25pm | Sunset Symposium |
| 03:55pm | Day Conclusion – Adjourn Valentin Del Rio, MD, FACC |
| Hour | Title |
|---|---|
| 07:00am | Continental Breakfast and Registration |
| 07:55am | Welcoming Remarks Valentín Del Río, MD, FACC President & Governor ACC PR Chapter Ricardo Santiago, MD, FACC President Scientific Program Committee |
| 08:00am | Session E: Transcatheter Valvular Interventions Transcatheter Edge-to-Edge Mitral Valve Repair: Current Status and Future Directions Pedro Colon, MD, FACC Does commercial experience then inform indication? A story about TAVR “Low-Risk” TAVR Hemal Gada, MD Contemporary Evaluation of Tricuspid Regurgitation in the Transcatheter Era Purvi Parwani, MD, FACC Transcatheter Tricuspid Valve Replacement: The New TAVR!!! Hemal Gada, MD |
| 09:20am | Discussion |
| 09:30am | Coffee Break – Exhibitor Visit |
| 09:45am | Session F: Contemporary Strategies and System Innovation in Cardiac Surgery Surgical Repair or Transcatheter Clip for Primary Mitral Regurgitation? Patrick McCarthy, MD, FACC Advancing Cardiac Surgical Quality in a U.S. Territory: Early Experience with Phase-of-Care Mortality Assessment Gonzalo Gonzalez, MD Surgical or Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis? Patrick McCarthy, MD, FACC |
| 10:45am | Master Lecture: José Eugenio López, MD, FACC Moderator: Ricardo Santiago, MD, FACC Building a Regional Adult Cardiac Surgery Network in Puerto Rico: Implementation, Outcomes and Future Directions Gonzalo Gonzalez, MD |
| 11:15am | Discussion |
| 11:25am | Coffee Break – Exhibitor Visit |
| 11:40am | Lunch Symposium |
| 01:00pm | Kick-off Symposium |
| 01:20pm | Session G: Fellows In-Training Moderator: Senior FITs Clinical Case – CCVPR The Hole Story: Left Ventricular Pseudoaneurysm from Infective Endocarditis Andres Garcia, MD Clinical Case – San Lucas Hospital Title: TBA Luis Colon, MD / Angel Ramos, MD Clinical Case – VACHCS Fix the Flow, Not the Valve: A Hemodynamic Strategy to Ebstein’s Anomaly Stephanie Ortiz, MD OR When Inferior Occlusion Myocardial Infarction Does Not Meet STEMI Criteria Diego Ortiz, MD Clinical Case – MMC Title: TBA Xavier Delgado, MD / Brian Torres, MD Clinical Case – MUSC Health Successful Outcomes with VT Ablation in Patients with Cardiac Amyloidosis Jomar Machuca, MD |
| 02:10pm | Coffee Break – Exhibitor Visit |
| 02:25pm | Session H: Hot Topics in Cardio-Oncology Advancing Cardio-Oncology: Scientific Progress and Clinical Priorities Bonnie Ky, MD, MSCE, FACC Coronary artery disease in cancer patients Juan Lopez-Mattei, MD, FACC Evolving Oncology Treatments and Cardiovascular Risk: Cardio-Oncology in 2026 Bonnie Ky, MD, MSCE, FACC |
| 03:25pm | Discussion |
| 03:35pm | State of the Chapter Valentin Del Rio, MD, FACC National ACC Update Bonnie Ky, MD, MSCE, FACC |
| 04:00pm | FIT Jeopardy 2026 |
| 04:35pm | FIT Poster and Oral Presentations Competition Winner Announcement |
| 04:40pm | Day Conclusion – Adjourn Valentin Del Rio, MD, FACC |

Need Assessment
The Puerto Rico Chapter of the American College of Cardiology, on its 36th Meeting, will provide the most updated information regarding the management of basic and complex cardiovascular diseases and practice improvement. A well-balanced scientific program has been developed, emphasizing appropriateness of care in patients with progressive and cardiovascular diseases and other relevant conditions carrying significant morbidity and mortality in our population. Also, will highlight the application of current guidelines, existing and new technologies, and breakthroughs in the management and prevention of cardiovascular diseases.
Educational Objectives for the ACC Puerto Rico Chapter 2026 Meeting:
- Analyze the most recent updates in the ACC/AHA guidelines for the management of acute coronary syndromes and their impact on contemporary clinical practice.
- Integrate evidence-based recommendations regarding antiplatelet therapy, anticoagulation strategies, and revascularization timing into the management of patients with STEMI and NSTEMI.
- Evaluate risk stratification tools and guideline-directed medical therapy to optimize short- and long-term outcomes in patients presenting with acute coronary syndromes.
- Evaluate the pathophysiologic relationship between obesity, cardiometabolic dysfunction, and the development and progression of heart failure, particularly HFpEF.
- Analyze current clinical trial data regarding the use of GLP-1 receptor agonists in patients with heart failure and obesity, including their effects on functional capacity, symptom burden, and cardiovascular outcomes.
- Integrate evidence-based weight management strategies, including pharmacologic therapy with GLP-1 receptor agonists, into comprehensive heart failure management to improve clinical outcomes and quality of life.
- Differentiate obstructive and non-obstructive hypertrophic cardiomyopathy phenotypes and their implications for therapeutic decision-making.
- Evaluate currently approved pharmacologic and interventional treatment options for hypertrophic cardiomyopathy, including novel cardiac myosin inhibitors, in the context of symptom burden and left ventricular outflow tract obstruction.
- Assess emerging therapies and evolving clinical trial data to inform individualized treatment strategies and optimize long-term outcomes in patients with hypertrophic cardiomyopathy.
- Differentiate transthyretin (ATTR) and light-chain (AL) cardiac amyloidosis based on pathophysiology, clinical presentation, and diagnostic strategies to guide appropriate management.
- Evaluate currently approved pharmacologic therapies for cardiac amyloidosis, including transthyretin stabilizers and gene-silencing agents, in the context of disease stage and patient characteristics.
- Assess emerging therapeutic agents and ongoing clinical trial data to inform timely referral, multidisciplinary care, and optimization of long-term outcomes in patients with cardiac amyloidosis.
- Evaluate current guideline recommendations and patient selection criteria for transcatheter aortic valve replacement (TAVR) in severe aortic stenosis across surgical risk categories.
- Analyze emerging evidence and technical considerations for the use of TAVR in patients with severe native aortic regurgitation, including anatomical challenges and procedural outcomes.
- Integrate contemporary imaging, heart team assessment, and device selection strategies to optimize procedural success and long-term outcomes in patients undergoing TAVR.
- Differentiate current indications and patient selection criteria for transcatheter mitral and tricuspid valve replacement based on valve pathology, anatomic considerations, and surgical risk.
- Evaluate contemporary clinical trial data and real-world outcomes supporting transcatheter mitral and tricuspid valve replacement therapies in patients with severe valvular heart disease.
- Differentiate traditional and emerging modalities for early detection of chemotherapy-related cardiac dysfunction, including biomarkers and advanced cardiac imaging techniques.
- Evaluate the role of strain imaging, cardiac MRI, and circulating biomarkers in identifying subclinical myocardial injury in patients receiving cardiotoxic cancer therapies.
- Integrate contemporary cardio-oncology surveillance strategies into clinical practice to enable early intervention and mitigate the progression of cancer therapy–related cardiac dysfunction.
*Subject to changes
| Hour | Title |
|---|---|
| 08:15am | Welcoming Remarks Abigail Matos Pagan, DNP, MS, APRN- RN, NHDP-BC, AACC CVT Section President |
| 08:30am | Prioritize preventive measures for cardiovascular health Miriam J. Nieto, PhD, RN, AAC |
| 09:05am | Cardio-obstetrics’: Care for women’s health Carla P. Rodríguez, MD, FACC |
| 09:35am | Echocardiography in Hypertrophic Cardiomyopathy Mariangely Rodriguez, MHSA, BS, RDCS |
| 10:15am | Coffee Break & Exhibitor Visit |
| 10:50am | The prognostic value of Frank’s crease Abigail Matos Pagan, DNP, MS, APRN- RN, NHDP-BC, AACC |
| 11:25am | Update on Hypertension Guidelines Dr. José Rivera del Rio, MD, FACC |
| 12:00pm | Lunch |
| 01:10pm | MD PROGRAM Session D: Electrophysiology Fundamentals & Advances Live Case: 3D-Mapping + FARAPULSE Pulsed Field Ablation (PFA) Operator: Hilton Franqui, MD, FACC / Francisco Perez, MD, FACC Non-thermal ablation Juan Sotomonte, MD, FACC Left Atrial Appendage Occlusion: The “Dual-Operator” Perspective Ricardo Perez, MD, FACC Newer Technologies in ICD Therapy (EV-ICD) Helder Hernandez, MD, FACC Leadless Pacing: Update 2026 Alfredo Lamela, MD |
| 03:00pm | Afternoon Break – Exhibitor Visit |
| 03:15pm | CARDIOVASCULAR TEAM APPLICATION DISCUSSION Moderator: Abigail Matos Pagan, DNP, MS, APRN- RN, NHDP-BC, AACC Miriam J. Nieto Vazquez, PhD, RN, AACC |
| 03:30pm | CVT Announcements & Adjourn |
| Hour | Title |
|---|---|
| 08:00am | Welcoming Remarks Miriam Nieto, PhD, AACC, RN- CVT Section Secretary |
| 08:30am | Partial Heart Transplant Raul Cota, MD, FACC |
| 09:00am | PAD: Risk and Management Darcy Diago, MD, FACC |
| 09:30am | Coffee Break & Exhibitor Visit |
| 09:50am | Stent Thrombosis Valentín J. Del Rio-Santiago, MD, FACC |
| 10:35am | Back to basic EKG Part I Marcos Velazquez, MD, FACC |
| 11:20am | Back to basic EKG Part II Marcos Velazquez, MD, FACC |
| 12:00pm | Lunch |
| 01:00pm | MD PROGRAM Session G: Fellows In-Training Moderator: Senior FITs Clinical Case – CCVPR The Hole Story: Left Ventricular Pseudoaneurysm from Infective Endocarditis Andres Garcia, MD Clinical Case – San Lucas Hospital Title: TBA Luis Colon, MD / Angel Ramos, MD Clinical Case – VACHCS Fix the Flow, Not the Valve: A Hemodynamic Strategy to Ebstein’s Anomaly Stephanie Ortiz, MD OR When Inferior Occlusion Myocardial Infarction Does Not Meet STEMI Criteria Diego Ortiz, MD Clinical Case – MMC Title: TBA Xavier Delgado, MD / Brian Torres, MD Clinical Case – MUSC Health Successful Outcomes with VT Ablation in Patients with Cardiac Amyloidosis Jomar Machuca, MD |
| 02:30pm | CARDIOVASCULAR TEAM APPLICATION DISCUSSION Moderators: Abigail Matos Pagan, DNP, MS, APRN- RN, NHDP-BC, AACC Miriam J. Nieto Vazque |
| 03:00pm | CVT Section Report Abigail Matos Pagan, DNP, MS, APRN- RN, NHDP-BC, AACC Miriam J. Nieto, PhD, RN, AACC |
Disclosure: This educational activity was submitted by the University of Puerto Rico Mayaguez Nursing Department for 12 CEU to the Puerto Rico Board of Nursing, Board of Radiographic and Radiotherapy Technology (sonography).
Registration was closed
Sheraton Puerto Rico Resort & Casino
200 Convention Blvd, San Juan, 00907
CONVENTION ROOM RATE NOT AVAILABE
For reservation contact:
Ilianis Tirado
Phone: 787-993-3500
